CI - Cigna Corp Stock Price, Fair Value and News

346.76USD+4.35 (+1.27%)Market Closed

Market Summary

USD346.76+4.35

Market Closed

1.27%

CI Alerts

Big fall in earnings (Y/Y)

Losses in recent quarter

CI Stock Price

View Fullscreen

CI RSI Chart

CI Valuation

Market Cap

98.5B

Price/Earnings (Trailing)

25.56

Price/Sales (Trailing)

0.48

EV/EBITDA

14.48

Price/Free Cashflow

8.47

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

1.94%

Return on Equity

9.32%

Return on Assets

2.52%

Free Cashflow Yield

11.8%

CI Fundamentals

CI Revenue

Revenue (TTM)

206.0B

Rev. Growth (Yr)

23.08%

Rev. Growth (Qtr)

12.01%

CI Earnings

Earnings (TTM)

3.9B

Earnings Growth (Yr)

-116.23%

Earnings Growth (Qtr)

-119.15%

Breaking Down CI Revenue

Last 7 days

-2.9%

Last 30 days

-4.3%

Last 90 days

4.9%

Trailing 12 Months

31.0%

How does CI drawdown profile look like?

CI Financial Health

Current Ratio

0.83

Debt/Equity

0.75

Debt/Cashflow

0.37

CI Investor Care

Dividend Yield

1.47%

Dividend/Share (TTM)

5.09

Buy Backs (1Y)

3.99%

Diluted EPS (TTM)

12.19

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	206.0B	0	0	0
2023	183.0B	186.1B	189.9B	195.3B
2022	177.1B	179.5B	180.4B	180.5B
2021	162.9B	166.8B	170.1B	174.1B
2020	154.1B	154.5B	156.9B	160.4B
2019	75.2B	102.5B	129.6B	153.6B
2018	42.8B	43.9B	45.0B	48.6B
2017	40.3B	40.8B	41.3B	41.8B
2016	0	0	0	39.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cigna Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 24, 2024	ozuah philip	acquired	-	-	539	-
Apr 24, 2024	granger elder	acquired	-	-	539	-
Apr 24, 2024	kurian george	acquired	-	-	539	-
Apr 24, 2024	ross kimberly a.	acquired	-	-	539	-
Apr 24, 2024	foss eric j	acquired	-	-	539	-
Apr 24, 2024	delaney william j iii	acquired	-	-	539	-
Apr 24, 2024	mcclellan mark b.	acquired	-	-	539	-
Apr 24, 2024	zarcone donna f	acquired	-	-	539	-
Apr 24, 2024	mazzarella kathleen m	acquired	-	-	539	-
Apr 24, 2024	hathi neesha	acquired	-	-	539	-

Which funds bought or sold CI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Wealth Advisors of Tampa Bay, LLC	unchanged	-	249,859	1,423,700	0.68%
May 06, 2024	BANQUE PICTET & CIE SA	added	28.75	12,894,200	35,856,300	0.34%
May 06, 2024	Merit Financial Group, LLC	added	169	630,870	935,534	0.02%
May 06, 2024	Jefferies Financial Group Inc.	added	6.6	98,904	952,251	0.01%
May 06, 2024	NewEdge Wealth, LLC	added	4.8	446,327	2,617,080	0.06%
May 06, 2024	Parallel Advisors, LLC	added	14.94	332,158	1,175,850	0.03%
May 06, 2024	Quantbot Technologies LP	sold off	-100	-5,956,060	-	-%
May 06, 2024	Schechter Investment Advisors, LLC	added	4.22	298,174	1,427,700	0.11%
May 06, 2024	Roundview Capital LLC	unchanged	-	248,458	1,415,720	0.12%
May 06, 2024	Metis Global Partners, LLC	reduced	-2.78	653,023	4,297,630	0.16%

Are Funds Buying or Selling CI?

Are funds buying CI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CI

No. of Funds

Unveiling Cigna Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	8.47%	24,775,082	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 25, 2024	blackrock inc.	8.4%	24,554,544	SC 13G/A
Feb 14, 2023	dodge & cox	3.8%	11,548,557	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	4.5%	13,656,608	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G
Feb 09, 2023	vanguard group inc	8.37%	25,583,766	SC 13G/A
Feb 07, 2023	blackrock inc.	9.0%	27,469,496	SC 13G
Feb 14, 2022	dodge & cox	5.3%	17,484,197	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	5.4%	17,961,332	SC 13G/A

Recent SEC filings of Cigna Corp

View All Filings

Date Filed	Form Type	Document
May 03, 2024	144	Notice of Insider Sale Intent
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	8-K	Current Report
Apr 26, 2024	8-K	Current Report
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading

Peers (Alternatives to Cigna Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	462.0B	371.6B	9.96%	1.73%	20.64	1.24	14.64%	11.24%
CI	98.5B	206.0B	-4.33%	31.01%	25.56	0.48	12.55%	-43.95%
HCA	82.4B	66.7B	-4.37%	13.20%	15.06	1.23	9.59%	-4.59%
CVS	70.0B	360.9B	-25.27%	-20.02%	9.55	0.19	9.07%	78.49%
CNC	40.5B	155.5B	4.29%	11.16%	14.81	0.26	6.34%	84.42%
DVA	12.1B	12.3B	3.05%	54.33%	14.8	0.98	5.77%	58.74%
UHS	11.7B	14.3B	-2.27%	18.37%	16.37	0.82	6.59%	6.24%
MID-CAP
CHE	8.8B	2.3B	-7.98%	4.98%	30.94	3.82	5.96%	18.29%
ACHC	6.3B	3.0B	-11.24%	-2.13%	-553.66	2.09	10.92%	-104.06%
AMN	2.3B	3.8B	3.83%	-33.34%	10.82	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.08%	8.52%	34.65	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.7B	1.1B	2.42%	25.02%	26.07	1.57	11.45%	30.74%
BKD	1.4B	3.0B	8.71%	84.46%	-7.37	0.46	6.74%	20.73%
BEAT	54.8M	-	-2.35%	-2.35%	-3.74	-	-	-12.94%
AMS	20.4M	21.3M	10.24%	15.77%	38.36	0.96	8.00%	-62.25%

Cigna Corp News

Latest updates

Cigna Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	12.0%	57,255	51,114	49,048	48,586	46,517	45,753	45,281	45,478	44,006	45,679	44,288	43,131	40,971	41,712	40,955	39,265	38,469	38,245	38,556	38,819	37,946
S&GA Expenses	-8.8%	3,705	4,062	3,788	3,434	3,538	3,484	3,151	3,264	3,275	3,644	3,093	2,996	3,279	3,966	3,301	3,407	3,398	3,957	3,413	3,380	3,303
EBITDA Margin	-19.8%	0.04*	0.05*	0.06*	0.07*	0.07*	0.07*	0.07*	0.06*	0.06*	0.06*	0.09*	0.09*	-	-	-	-	-	-	-	-	-
Interest Expenses	8.0%	336	311	387	310	322	306	308	307	308	303	311	308	331	327	369	348	395	388	392	488	377
Income Taxes	131.7%	291	-919	391	374	295	136	713	411	355	182	424	422	342	1,236	406	529	208	277	409	348	416
Earnings Before Taxes	-58.0%	79.00	188	1,840	1,884	1,601	1,358	3,491	1,981	1,567	1,320	2,059	1,898	1,513	5,378	1,804	2,289	1,397	1,261	1,763	1,758	1,788
EBT Margin	-31.4%	0.02*	0.03*	0.04*	0.04*	0.05*	0.05*	0.05*	0.04*	0.04*	0.04*	0.06*	0.06*	-	-	-	-	-	-	-	-	-
Net Income	-119.2%	-212	1,107	1,449	1,510	1,306	1,222	2,778	1,570	1,212	1,138	1,635	1,476	1,171	4,142	1,398	1,760	1,189	977	1,354	1,410	1,372
Net Income Margin	-32.0%	0.02*	0.03*	0.03*	0.04*	0.04*	0.04*	0.04*	0.03*	0.03*	0.03*	0.05*	0.05*	-	-	-	-	-	-	-	-	-
Free Cashflow	229.9%	4,840	1,467	2,516	2,182	4,718	1,789	2,973	934	1,720	3,965	1,809	-606	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.2%	153,119	152,761	149,645	150,054	147,976	143,885	144,209	152,630	152,610	154,889	154,251	154,207	152,081	155,451	160,044	159,628	154,711	155,774	154,847	154,401	154,348
Current Assets	16.1%	43,357	37,351	34,518	34,711	32,027	30,122	30,170	37,422	35,393	36,134	25,487	25,011	25,554	27,799	34,557	34,880	30,877	29,845	21,168	20,709	21,136
Cash Equivalents	8.5%	8,484	7,822	8,497	9,585	7,935	5,924	7,117	4,468	4,469	5,123	3,540	3,878	6,544	4,157	5,406	7,185	4,452	-	4,577	3,610	4,976
Inventory	-18.0%	4,630	5,645	4,416	4,514	4,211	4,777	4,017	3,781	3,500	3,722	3,020	3,042	2,919	3,165	2,657	2,712	2,565	2,661	2,160	2,298	2,382
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,417	4,448	4,538	4,523
Goodwill	0.0%	44,258	44,259	45,810	45,811	45,811	45,811	45,807	45,810	45,804	45,811	46,056	46,063	44,635	44,648	44,685	44,590	44,584	44,602	44,462	44,449	44,537
Liabilities	5.0%	111,769	106,410	103,879	104,528	103,380	99,131	99,076	106,663	106,446	107,705	106,768	105,440	103,867	105,065	111,946	112,223	109,590	110,395	110,114	110,552	111,897
Current Liabilities	6.7%	51,977	48,716	47,059	47,345	44,727	41,225	41,115	45,218	43,662	43,572	36,340	34,711	33,470	36,022	43,886	42,179	40,380	40,138	34,447	31,867	32,969
Long Term Debt	10.3%	31,053	28,155	28,094	28,115	29,124	28,100	28,090	30,984	31,013	31,125	31,609	31,606	31,568	29,545	29,537	31,774	32,147	31,893	34,041	36,885	37,571
Shareholder's Equity	-10.5%	41,350	46,223	45,691	45,464	44,518	44,675	44,806	45,701	46,145	46,976	47,427	48,716	48,155	50,189	48,039	47,371	45,086	45,344	44,699	43,818	42,413
Retained Earnings	-1.6%	40,978	41,652	40,982	39,936	38,841	37,940	37,041	34,626	33,420	32,593	31,803	30,513	29,389	28,575	24,440	23,052	21,298	20,162	19,185	17,834	16,426
Additional Paid-In Capital	-1.2%	30,292	30,669	30,563	30,436	30,332	30,233	29,395	29,930	29,736	29,574	29,077	29,403	29,254	28,975	28,777	28,699	28,554	28,306	28,115	27,891	27,855
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	372	373	378	379
Minority Interest	704.8%	169	21.00	11.00	19.00	16.00	13.00	42.00	30.00	22.00	18.00	12.00	7.00	6.00	7.00	7.00	5.00	7.00	6.00	3.00	3.00	5.00
Float	-	-	-	-	82,800	-	-	-	82,800	-	-	-	80,800	-	-	-	68,900	-	-	-	59,400	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	229.9%	4,840	1,467	2,826	2,492	5,028	2,099	3,283	1,244	2,030	4,275	2,119	-296	1,093	4,294	895	3,274	1,887	2,793	2,461	1,039	3,192
Cashflow From Investing	-12.5%	-495	-440	-1,337	-414	-2,983	-616	4,446	-408	-324	123	-710	-2,307	-717	4,420	-938	-237	-269	-271	-304	-634	475
Cashflow From Financing	-102.3%	-2,529	-1,250	-2,572	-435	-37.00	-2,636	-5,517	-916	-2,171	-2,371	-1,728	-62.00	-4,051	-4,721	-1,682	-312	-1,818	-1,707	-1,173	-1,773	-2,534
Dividend Payments	-100.0%	-	358	362	362	368	334	341	352	357	324	330	342	345	-	-	15.00	-	-	-	-	-
Buy Backs	639.3%	4,022	544	624	154	962	1,733	3,500	1,006	1,368	1,421	2,611	916	2,794	1,690	1,028	368	956	447	674	404	462

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CI Income Statement

2024-03-31

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Revenues
Premiums	$ 11,603	$ 11,025
Net investment income	290	277
TOTAL REVENUES	57,255	46,517
Benefits and expenses
Pharmacy and other service costs	41,431	31,459
Medical costs and other benefit expenses	9,440	9,046
Selling, general and administrative expenses	3,705	3,538
Amortization of acquired intangible assets	423	459
TOTAL BENEFITS AND EXPENSES	54,999	44,502
Income from operations	2,256	2,015
Interest expense and other	(322)	(358)
Loss on sale of businesses	(19)	0
Net realized investment losses	(1,836)	(56)
Income before income taxes	79	1,601
TOTAL INCOME TAXES	291	295
Net (loss) income	(212)	1,306
Less: Net income attributable to noncontrolling interests	65	39
SHAREHOLDERS' NET (LOSS) INCOME	$ (277)	$ 1,267
Shareholders' net (loss) income per share
Basic (in dollars per share)	$ (0.97)	$ 4.28
Diluted (in dollars per share)	$ (0.97)	$ 4.24
Pharmacy revenues
Revenues
Revenues	$ 42,036	$ 32,144
Fees and other revenues
Revenues
Revenues	$ 3,326	$ 3,071

CI Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($)
$ in Millions

Mar. 31, 2024

Dec. 31, 2023

Assets

Cash and cash equivalents

$ 8,439

$ 7,822

Investments

1,108

925

Accounts receivable, net

20,563

17,722

Inventories

4,630

5,645

Other current assets

2,263

2,169

Assets of businesses held for sale

6,354

3,068

Total current assets

43,357

37,351

Long-term investments

16,025

17,985

Reinsurance recoverables

4,672

4,835

Property and equipment

3,607

3,695

Goodwill

44,258

44,259

Other intangible assets

30,491

30,863

Other assets

3,293

3,421

Separate account assets

7,416

7,430

Assets of businesses held for sale, non-current

2,922

TOTAL ASSETS

153,119

152,761

Liabilities

Current insurance and contractholder liabilities

5,788

5,514

Pharmacy and other service costs payable

24,284

19,815

Accounts payable

8,118

8,553

Accrued expenses and other liabilities

8,857

9,955

Short-term debt

1,715

2,775

Liabilities of businesses held for sale

3,215

2,104

Total current liabilities

51,977

48,716

Non-current insurance and contractholder liabilities

10,641

10,904

Deferred tax liabilities, net

7,029

7,173

Other non-current liabilities

3,653

3,441

Long-term debt

31,053

28,155

Separate account liabilities

7,416

7,430

Liabilities of businesses held for sale, non-current

591

TOTAL LIABILITIES

111,769

106,410

Contingencies — Note 16

Redeemable noncontrolling interests

107

Shareholders' equity

Common stock

^[1]

Additional paid-in capital

30,292

30,669

Accumulated other comprehensive loss

(2,324)

(1,864)

Retained earnings

40,978

41,652

Less: Treasury stock, at cost

(27,769)

(24,238)

TOTAL SHAREHOLDERS' EQUITY

41,181

46,223

Other noncontrolling interests

169

Total equity

41,350

46,244

Total liabilities and equity

$ 153,119

$ 152,761

[1]	Par value per share, $0.01; shares issued, 402 million as of March 31, 2024 and 400 million as of December 31, 2023; authorized shares, 600 million.

About Cigna Corp

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CEO	Mr. David Michael Cordani
WEBSITE	cigna.com
INDUSTRY	Healthcare Plans
EMPLOYEES	65535

Cigna Corp Frequently Asked Questions

What is the ticker symbol for Cigna Corp? What does CI stand for in stocks?

CI is the stock ticker symbol of Cigna Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cigna Corp (CI)?

As of Tue May 07 2024, market cap of Cigna Corp is 98.51 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers.

What is the fair value of CI stock?

You can check CI's fair value in chart for subscribers. The fair value of Cigna Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cigna Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cigna Corp a good stock to buy?

The fair value guage provides a quick view whether CI is over valued or under valued. Whether Cigna Corp is cheap or expensive depends on the assumptions which impact Cigna Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CI.

What is Cigna Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, CI's PE ratio (Price to Earnings) is 25.56 and Price to Sales (PS) ratio is 0.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Cigna Corp's stock?

In the past 10 years, Cigna Corp has provided 0.154 (multiply by 100 for percentage) rate of return.